Overview

Fall Prevention in Older Adults With OAB

Status:
Completed
Trial end date:
2017-07-19
Target enrollment:
Participant gender:
Summary
Though OAB treatment may improve physical activity, there is a lack of easily administered instruments for measuring physical activity in older adults. Aim is to validate instruments to measure physical activity and preference for medication, and to determine the effect of preference for anti-cholinergic medication on adherence, physical activity, and falls risk. It's plan a prospective cohort study of adults aged 65 or older with OAB undergoing treatment with anti-cholinergic medication.
Phase:
Phase 4
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
Pfizer
Treatments:
Fesoterodine